University of Virginia Couric Cancer Center

Charlottesville, VA. Team Draft will be touring the University of VA Couric Cancer Center to speak with their lung cancer team of oncologists and researchers about the centers’ latest treatment options and advances.

The University of Virginia (UVA) Cancer Center was founded in 1984 and received its NCI designation in 1987. The Center’s vision is of a collaborative approach to basic and translational research coupled with the delivery of multi-specialty, patient-centered care.

The special mission of the Center is to identify new frontiers of knowledge that can be brought to bear in the fight against cancer. UVA has a long tradition of discovery research in cancer cell regulation, especially in the area of signal transduction. To that end, the Center has fostered partnerships between molecular pharmacologists and tumor virologists, which spearheaded the creation of the cancer cell signaling field. The Center has worked with the private sector to translate discoveries into useful tools for cancer care.

The Center draws more than 130 researchers from 22 different academic departments. UVA’s research activities are organized around five programs that combine a foundation of basic science with translational or clinical components: Chemical and Structural Biology, Molecular Genetics and Epigenetics, Cancer Cell Signaling, Women’s Oncology, and Cancer Immunology and Immunotherapy.